Glant T T, Mikecz K, Poole A R
Biochem J. 1986 Feb 15;234(1):31-41. doi: 10.1042/bj2340031.
Monoclonal antibodies produced against chondroitinase-treated human adult cartilage proteoglycans were selected for their ability to recognize epitopes on native proteoglycans. Binding analyses revealed that four of these monoclonal antibodies (BCD-4, BCD-7, EFG-4 and KPC-190) each recognized a different epitope on the same proteoglycan molecule which represents a subpopulation of a high buoyant density (D1) fraction of human articular cartilage proteoglycans (10, 30, 50 and 60% in fetal-newborn, 1.5 years old, 15 years old and 52-56 years old cartilages, respectively). Analysis of epitope specificities revealed that BCD-7 and EFG-4 monoclonal antibodies recognized epitopes on proteoglycan monomer which are associated with the protein structure in that they are sensitive to cleavage by Pronase, papain and alkali treatment and do not include keratan sulphate, chondroitin sulphate or oligosaccharides. The BCD-4 and KPC-190 epitopes also proved to be sensitive to Pronase or papain digestion or to alkali treatment, but keratanase or endo-beta-galactosidase also reduced the immunoreactivity of these epitopes. These observations indicate that the BCD-4 and KPC-190 epitopes represent peptides substituted with keratan sulphate or keratan sulphate-like structures. The BCD-4 epitope is, however, absent from a keratan sulphate-rich fragment of human adult proteoglycan, while the other three epitopes were detected in this fragment. None of these four epitopes were detected in the link proteins of human cartilage, in the hyaluronic acid-binding region of human newborn cartilage proteoglycan, in Swarm rat chondrosarcoma proteoglycan, in chicken limb bud proteoglycan monomer and in the small dermatan sulphate-proteoglycan of bovine costal cartilage. EFG-4 and KPC-190 epitopes were not detected in human fetal cartilage proteoglycans, although fetal molecules contained trace amounts of epitopes reactive with BCD-4 and BCD-7 antibodies.
针对软骨素酶处理的成人人类软骨蛋白聚糖产生的单克隆抗体,因其识别天然蛋白聚糖表位的能力而被挑选出来。结合分析表明,这些单克隆抗体中的四种(BCD - 4、BCD - 7、EFG - 4和KPC - 190)各自识别同一蛋白聚糖分子上的不同表位,该分子代表人类关节软骨蛋白聚糖高浮力密度(D1)组分的一个亚群(分别在胎儿 - 新生儿、1.5岁、15岁和52 - 56岁软骨中占10%、30%、50%和60%)。表位特异性分析表明,BCD - 7和EFG - 4单克隆抗体识别蛋白聚糖单体上与蛋白质结构相关的表位,因为它们对链霉蛋白酶、木瓜蛋白酶和碱处理敏感,且不包括硫酸角质素、硫酸软骨素或寡糖。BCD - 4和KPC - 190表位也被证明对链霉蛋白酶或木瓜蛋白酶消化或碱处理敏感,但角质酶或内切β - 半乳糖苷酶也降低了这些表位的免疫反应性。这些观察结果表明,BCD - 4和KPC - 190表位代表被硫酸角质素或硫酸角质素样结构取代的肽段。然而,成人人类蛋白聚糖富含硫酸角质素的片段中不存在BCD - 4表位,而其他三个表位在此片段中被检测到。在人类软骨的连接蛋白、人类新生儿软骨蛋白聚糖的透明质酸结合区域、群体大鼠软骨肉瘤蛋白聚糖、鸡肢芽蛋白聚糖单体以及牛肋软骨的小硫酸皮肤素蛋白聚糖中均未检测到这四个表位中的任何一个。在人类胎儿软骨蛋白聚糖中未检测到EFG - 4和KPC - 190表位,尽管胎儿分子含有痕量与BCD - 4和BCD - 7抗体反应的表位。